10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 364 filers reported holding 10X GENOMICS INC in Q4 2021. The put-call ratio across all filers is 0.41 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,387,235 | -51.4% | 494,236 | -34.1% | 6.48% | -35.4% |
| Q2 2023 | $41,908,032 | +0.1% | 750,502 | 0.0% | 10.04% | +14.0% |
| Q1 2023 | $41,870,507 | +8.2% | 750,502 | -29.3% | 8.80% | -6.7% |
| Q4 2022 | $38,687,692 | +27.9% | 1,061,682 | 0.0% | 9.44% | +82.8% |
| Q3 2022 | $30,237,000 | -37.1% | 1,061,682 | 0.0% | 5.16% | -30.6% |
| Q2 2022 | $48,041,000 | -52.7% | 1,061,682 | -20.5% | 7.43% | -22.5% |
| Q1 2022 | $101,649,000 | -57.6% | 1,336,253 | -17.0% | 9.59% | +24.9% |
| Q4 2021 | $239,948,000 | -8.1% | 1,610,824 | -10.2% | 7.68% | -1.5% |
| Q3 2021 | $261,152,000 | -25.7% | 1,793,871 | 0.0% | 7.80% | +3.9% |
| Q2 2021 | $351,276,000 | -8.6% | 1,793,871 | -15.5% | 7.51% | -20.8% |
| Q1 2021 | $384,327,000 | +5.2% | 2,123,356 | -17.7% | 9.48% | -69.1% |
| Q4 2020 | $365,466,000 | – | 2,580,975 | – | 30.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |